Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings

Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay, Jan Deenan, Silvia Bertagnolio, Charles Boucher, Francoise Brun-Vezinet, Bonaventura Clotet, Carlo Giaquinto, Carlo F. Perno

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

Original languageEnglish
Pages (from-to)831-836
Number of pages6
JournalAntiviral Therapy
Volume18
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Anti-HIV Agents
Drug Resistance
HIV
Education
Mothers
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings : Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. / Pillay, Deenan; Deenan, Jan; Bertagnolio, Silvia; Boucher, Charles; Brun-Vezinet, Francoise; Clotet, Bonaventura; Giaquinto, Carlo; Perno, Carlo F.

In: Antiviral Therapy, Vol. 18, No. 6, 2013, p. 831-836.

Research output: Contribution to journalArticle

Pillay, Deenan ; Deenan, Jan ; Bertagnolio, Silvia ; Boucher, Charles ; Brun-Vezinet, Francoise ; Clotet, Bonaventura ; Giaquinto, Carlo ; Perno, Carlo F. / Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings : Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. In: Antiviral Therapy. 2013 ; Vol. 18, No. 6. pp. 831-836.
@article{f2063f024c0a4806960858b1f37807eb,
title = "Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network",
abstract = "Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.",
author = "Deenan Pillay and Jan Deenan and Silvia Bertagnolio and Charles Boucher and Francoise Brun-Vezinet and Bonaventura Clotet and Carlo Giaquinto and Perno, {Carlo F.}",
year = "2013",
doi = "10.3851/IMP2650",
language = "English",
volume = "18",
pages = "831--836",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "6",

}

TY - JOUR

T1 - Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings

T2 - Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

AU - Pillay, Deenan

AU - Deenan, Jan

AU - Bertagnolio, Silvia

AU - Boucher, Charles

AU - Brun-Vezinet, Francoise

AU - Clotet, Bonaventura

AU - Giaquinto, Carlo

AU - Perno, Carlo F.

PY - 2013

Y1 - 2013

N2 - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

AB - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

UR - http://www.scopus.com/inward/record.url?scp=84890364624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890364624&partnerID=8YFLogxK

U2 - 10.3851/IMP2650

DO - 10.3851/IMP2650

M3 - Article

VL - 18

SP - 831

EP - 836

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 6

ER -